Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid

被引：0
|
作者：
Kridin, Khalaf [1 ,2 ,3 ]
Hammers, Christoph M. [1 ,4 ]
机构：
[1] Univ Lubeck, Lubeck Inst Expt Dermatol LIED, Lubeck, Germany
[2] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel
[3] Barch Padeh Med Ctr, Unit Dermatol & Skin Res Lab, Poriya, Israel
[4] Christian Albrechts Univ Kiel, Dept Dermatol, Kiel, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 06期
关键词：
D O I：
10.1111/bjd.21882
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：843 / 844
页数：2
相关论文
共 50 条
  • [41] Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis A Narrative Review
    Lehmann, Lorenz H.
    Cautela, Jennifer
    Palaskas, Nicolas
    Baik, Alan H.
    Meijers, Wouter C.
    Allenbach, Yves
    Alexandre, Joachim
    Rassaf, Tienush
    Muller, Oliver J.
    Aras, Mandar
    Asnani, Aarti H.
    Deswal, Anita
    Laufer-Perl, Michal
    Thuny, Franck
    Kerneis, Mathieu
    Hayek, Salim S.
    Ederhy, Stephane
    Salem, Joe-Elie
    Moslehi, Javid J.
    JAMA CARDIOLOGY, 2021, 6 (11) : 1329 - 1337
  • [42] Clinical and immunological analyses of immune checkpoint inhibitor-associated neuromuscular (NM) toxicities.
    Siddiqui, Bilal A.
    Durand, Jean-Bernard
    Gao, Jianjun
    Wang, Jianbo
    Aparicio, Ana
    Campbell, Matthew T.
    Siefker-Radtke, Arlene O.
    Tannir, Nizar M.
    Corn, Paul Gettys
    Msaouel, Pavlos
    Shah, Amishi Yogesh
    Zurita, Amado J.
    Tu, Shi-Ming
    Suarez-Almazor, Maria E.
    Sudhakar, Tummala
    Logothetis, Christopher
    Sharma, Padmanee
    Subudhi, Sumit Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Sick Sinus Syndrome: More Than a Needle-in-a-haystack Manifestation of Immune Checkpoint Inhibitor-associated Myocarditis
    Kadowaki, Hiroshi
    Akazawa, Hiroshi
    INTERNAL MEDICINE, 2022, 61 (14) : 2101 - 2102
  • [44] Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers
    Sadik, Christian D.
    Langan, Ewan A.
    Gutzmer, Ralf
    Fleischer, Maria Isabel
    Loquai, Carmen
    Reinhardt, Lydia
    Meier, Friedegund
    Goeppner, Daniela
    Herbst, Rudolf A.
    Zillikens, Detlef
    Terheyden, Patrick
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [45] Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases
    Leaf, Rebecca Karp
    Ferreri, Christopher
    Reynolds, Kerry Lynn
    Rangachari, Deepa
    Mier, James
    Witteles, Wesley
    Ansstas, George
    Anagnostou, Theodora
    Zubiri, Leyre
    Piotrowska, Zofia
    Oo, Thein H.
    Iberri, David
    Yarchoan, Mark
    Salama, April
    Rahma, Osama
    Leaf, David
    BLOOD, 2018, 132
  • [46] Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
    Puzanov, Igor
    Subramanian, Poornima
    Yatsynovich, Yan, V
    Jacobs, David M.
    Chilbert, Maya R.
    Sharma, Umesh C.
    Ito, Fumito
    Feuerstein, Steven G.
    Stefanovic, Filip
    Switzer, Benjamin
    Hicar, Mark D.
    Curtis, Anne B.
    Spangenthal, Edward J.
    Dy, Grace K.
    Ernstoff, Marc S.
    Vachhani, Pankit
    Page, Brian J.
    Agrawal, Nikhil
    Khunger, Arjun
    Kapoor, Ankita
    Hattoum, Alexander
    Jerome, Schentag J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [47] Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
    Yang, Ting-Ya
    Chuang, Min-Hsiang
    Lin, Hong-Min
    Wu, Vin-Cent
    Pan, Heng-Chih
    Chou, Yun
    Chen, Jui-Yi
    BMJ OPEN, 2025, 15 (02):
  • [48] Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180
    Mai, Yosuke
    Nishie, Wataru
    Izumi, Kentaro
    Shimizu, Hiroshi
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [49] Dramatic deterioration or new-onset dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid after COVID-19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome
    Sunada, Midori
    Sugiyama, Seiko
    Nakahara, Yukiko
    Yamane, Mariko
    Mashiko, Rehito
    Yamamoto, Takenobu
    Aoyama, Yumi
    JEADV CLINICAL PRACTICE, 2023, 2 (03): : 479 - 487
  • [50] Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
    Iwamoto, Yuichiro
    Anno, Takatoshi
    Koyama, Katsumasa
    Kawasaki, Fumiko
    Kaku, Kohei
    Tomoda, Koichi
    Sugiyama, Seiko
    Aoyama, Yumi
    Kaneto, Hideaki
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345